カテゴリー： Transparency Market Research, 世界, 医療/バイオ

血液検査の世界市場2022～2032：検査種類別、地域別

◆英語タイトル：Global Blood Testing Market by Test Type (Glucose, A1C, Direct LDL, Lipid Panel, Prostate-specific Antigen, Covid-19, BUN Testing, Vitamin D, Testosterone, ALT, Creatinine, Other Test Types) and Region - 2022 to 2032

Transparency Market Researchが発行した調査報告書（TMR23FB013）◆商品コード：TMR23FB013
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2022年12月27日
◆ページ数：250
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社は、2022年に875億ドルであった世界の血液検査市場規模が2032年には2182億ドルまで拡大し、予測期間中にCAGR 9.6％増加すると見込んでいます。本資料では、血液検査の世界市場を総合的に調査・分析を行い、エグゼクティブサマリー、市場概要、市場の背景、血液検査の世界市場分析・予測、検査種類別（グルコース、A1C、ダイレクトLDL、脂質パネル、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競合分析、仮定、調査手法などの内容を調査資料にまとめました。なお、本資料では、Abbott、F. Hoffmann-La Roche AG、Bio-Rad Laboratories, Inc.、BioMerieux SA、Quest Diagnostics、Biomerica, Inc.、Becton, Dickinson and Company、Siemens Healthineers、Danaher Corporation、Trinity Biotech Plcなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・市場の背景
・血液検査の世界市場分析・予測
・世界の血液検査市場規模：検査種類別
- グルコース血液検査の市場規模
- A1C血液検査の市場規模
- ダイレクトLDL血液検査の市場規模
- 脂質パネル血液検査の市場規模
- その他血液検査の市場規模
・世界の血液検査市場規模：地域別
- 北米の血液検査市場規模
- 中南米の血液検査市場規模
- ヨーロッパの血液検査市場規模
- アジア太平洋の血液検査市場規模
- 中東・アフリカの血液検査市場規模
・市場構造分析
・競合分析
・仮定
・調査手法

Blood Testing Market – Scope of Report
TMR’s report on the global blood testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global blood testing market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood testing market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the blood testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global blood testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood testing market.

The report delves into the competitive landscape of the global blood testing market. Key players operating in the global blood testing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global blood testing market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market blood testing.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity 
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Investment Feasibility Matrix
    3.6. PESTLE and Porter’s Analysis
    3.7. Regulatory Landscape
        3.7.1. By Key Regions
        3.7.2. By Key Countries
    3.8. Regional Parent Market Outlook
4. Global Blood Testing Market Analysis 2015-2021 and Forecast, 2022-2032
    4.1. Historical Market Size Value (US$ Mn) Analysis, 2015-2021
    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2015-2021
    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032
        5.3.1. Glucose
        5.3.2. A1C
        5.3.3. Direct LDL
        5.3.4. Lipid panel
        5.3.5. Prostate-specific antigen
        5.3.6. COVID-19
        5.3.7. Bun testing
        5.3.8. Vitamin D
        5.3.9. Testosterone
        5.3.10. ALT
        5.3.11. Creatinine
        5.3.12. Other Test Types
    5.4. Y-o-Y Growth Trend Analysis By Test Type, 2015-2021
    5.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032
6. Global Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Region
    6.1. Introduction
    6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2015-2021
    6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
        6.3.1. North America
        6.3.2. Latin America
        6.3.3. Europe
        6.3.4. Asia Pacific
        6.3.5. Middle East and Africa
    6.4. Market Attractiveness Analysis By Region
7. North America Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
    7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
    7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        7.2.1. By Country
            7.2.1.1. U.S.
            7.2.1.2. Canada
        7.2.2. By Test Type
    7.3. Market Attractiveness Analysis
        7.3.1. By Country
        7.3.2. By Test Type
    7.4. Key Takeaways
8. Latin America Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        8.2.1. By Country
            8.2.1.1. Brazil
            8.2.1.2. Mexico
            8.2.1.3. Rest of Latin America
        8.2.2. By Test Type
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Test Type
    8.4. Key Takeaways
9. Europe Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        9.2.1. By Country
            9.2.1.1. Germany
            9.2.1.2. U.K.
            9.2.1.3. France
            9.2.1.4. Spain
            9.2.1.5. Italy
            9.2.1.6. Russia
            9.2.1.7. Rest of Europe
        9.2.2. By Test Type
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Test Type
    9.4. Key Takeaways
10. Asia Pacific Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        10.2.1. By Country
            10.2.1.1. China
            10.2.1.2. Japan
            10.2.1.3. India
            10.2.1.4. South Korea
            10.2.1.5. Australia
            10.2.1.6. Rest of APAC
        10.2.2. By Test Type
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Test Type
    10.4. Key Takeaways
11. Middle East and Africa Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        11.2.1. By Country
            11.2.1.1. South Africa
            11.2.1.2. Saudi Arabia
            11.2.1.3. UAE
            11.2.1.4. Israel
            11.2.1.5. Rest of MEA
        11.2.2. By Test Type
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Test Type
    11.4. Key Takeaways
12. Key Countries Blood Testing Market Analysis
    12.1. U.S.
        12.1.1. Pricing Analysis
        12.1.2. Market Share Analysis, 2021
            12.1.2.1. By Test Type
    12.2. Canada
        12.2.1. Pricing Analysis
        12.2.2. Market Share Analysis, 2021
            12.2.2.1. By Test Type
    12.3. Brazil
        12.3.1. Pricing Analysis
        12.3.2. Market Share Analysis, 2021
            12.3.2.1. By Test Type
    12.4. Mexico
        12.4.1. Pricing Analysis
        12.4.2. Market Share Analysis, 2021
            12.4.2.1. By Test Type
    12.5. Germany
        12.5.1. Pricing Analysis
        12.5.2. Market Share Analysis, 2021
            12.5.2.1. By Test Type
    12.6. U.K.
        12.6.1. Pricing Analysis
        12.6.2. Market Share Analysis, 2021
            12.6.2.1. By Test Type
    12.7. France
        12.7.1. Pricing Analysis
        12.7.2. Market Share Analysis, 2021
            12.7.2.1. By Test Type
    12.8. Spain
        12.8.1. Pricing Analysis
        12.8.2. Market Share Analysis, 2021
            12.8.2.1. By Test Type
    12.9. Italy
        12.9.1. Pricing Analysis
        12.9.2. Market Share Analysis, 2021
            12.9.2.1. By Test Type
    12.10. Russia
        12.10.1. Pricing Analysis
        12.10.2. Market Share Analysis, 2021
            12.10.2.1. By Test Type
    12.11. China
        12.11.1. Pricing Analysis
        12.11.2. Market Share Analysis, 2021
            12.11.2.1. By Test Type
    12.12. Japan
        12.12.1. Pricing Analysis
        12.12.2. Market Share Analysis, 2021
            12.12.2.1. By Test Type
    12.13. India
        12.13.1. Pricing Analysis
        12.13.2. Market Share Analysis, 2021
            12.13.2.1. By Test Type
    12.14. South Korea
        12.14.1. Pricing Analysis
        12.14.2. Market Share Analysis, 2021
            12.14.2.1. By Test Type
    12.15. Australia
        12.15.1. Pricing Analysis
        12.15.2. Market Share Analysis, 2021
            12.15.2.1. By Test Type
    12.16. South Africa
        12.16.1. Pricing Analysis
        12.16.2. Market Share Analysis, 2021
            12.16.2.1. By Test Type
    12.17. Saudi Arabia
        12.17.1. Pricing Analysis
        12.17.2. Market Share Analysis, 2021
            12.17.2.1. By Test Type
    12.18. UAE
        12.18.1. Pricing Analysis
        12.18.2. Market Share Analysis, 2021
            12.18.2.1. By Test Type
    12.19. Israel
        12.19.1. Pricing Analysis
        12.19.2. Market Share Analysis, 2021
            12.19.2.1. By Test Type
13. Market Structure Analysis
    13.1. Competition Dashboard
    13.2. Competition Benchmarking
    13.3. Market Share Analysis of Top Players
        13.3.1. By Regional
        13.3.2. By Test Type
14. Competition Analysis
    14.1. Competition Deep Dive
        14.1.1. Abbott
            14.1.1.1. Overview
            14.1.1.2. Product Portfolio
            14.1.1.3. Profitability by Market Segments
            14.1.1.4. Sales Footprint
            14.1.1.5. Strategy Overview
                14.1.1.5.1. Marketing Strategy
        14.1.2. F. Hoffmann-La Roche AG
            14.1.2.1. Overview
            14.1.2.2. Product Portfolio
            14.1.2.3. Profitability by Market Segments
            14.1.2.4. Sales Footprint
            14.1.2.5. Strategy Overview
                14.1.2.5.1. Marketing Strategy
        14.1.3. Bio-Rad Laboratories, Inc.
            14.1.3.1. Overview
            14.1.3.2. Product Portfolio
            14.1.3.3. Profitability by Market Segments
            14.1.3.4. Sales Footprint
            14.1.3.5. Strategy Overview
                14.1.3.5.1. Marketing Strategy
        14.1.4. BioMerieux SA
            14.1.4.1. Overview
            14.1.4.2. Product Portfolio
            14.1.4.3. Profitability by Market Segments
            14.1.4.4. Sales Footprint
            14.1.4.5. Strategy Overview
                14.1.4.5.1. Marketing Strategy
        14.1.5. Quest Diagnostics
            14.1.5.1. Overview
            14.1.5.2. Product Portfolio
            14.1.5.3. Profitability by Market Segments
            14.1.5.4. Sales Footprint
            14.1.5.5. Strategy Overview
                14.1.5.5.1. Marketing Strategy
        14.1.6. Biomerica, Inc.
            14.1.6.1. Overview
            14.1.6.2. Product Portfolio
            14.1.6.3. Profitability by Market Segments
            14.1.6.4. Sales Footprint
            14.1.6.5. Strategy Overview
                14.1.6.5.1. Marketing Strategy
        14.1.7. Becton, Dickinson and Company
            14.1.7.1. Overview
            14.1.7.2. Product Portfolio
            14.1.7.3. Profitability by Market Segments
            14.1.7.4. Sales Footprint
            14.1.7.5. Strategy Overview
                14.1.7.5.1. Marketing Strategy
        14.1.8. Siemens Healthineers
            14.1.8.1. Overview
            14.1.8.2. Product Portfolio
            14.1.8.3. Profitability by Market Segments
            14.1.8.4. Sales Footprint
            14.1.8.5. Strategy Overview
                14.1.8.5.1. Marketing Strategy
        14.1.9. Danaher Corporation
            14.1.9.1. Overview
            14.1.9.2. Product Portfolio
            14.1.9.3. Profitability by Market Segments
            14.1.9.4. Sales Footprint
            14.1.9.5. Strategy Overview
                14.1.9.5.1. Marketing Strategy
        14.1.10. Trinity Biotech Plc
            14.1.10.1. Overview
            14.1.10.2. Product Portfolio
            14.1.10.3. Profitability by Market Segments
            14.1.10.4. Sales Footprint
            14.1.10.5. Strategy Overview
                14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology

List of Tables

Table 1: Global Blood Testing Market Value (US$ Mn) Forecast by Region, 2015-2032

Table 2: Global Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032

Table 3: North America Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 4: North America Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032

Table 5: Latin America Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 6: Latin America Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032

Table 7: Europe Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 8: Europe Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032

Table 9: Asia Pacific Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 10: Asia Pacific Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032

Table 11: Middle East and Africa Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032

Table 12: Middle East and Africa Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 血液検査の世界市場2022～2032：検査種類別、地域別(Global Blood Testing Market by Test Type (Glucose, A1C, Direct LDL, Lipid Panel, Prostate-specific Antigen, Covid-19, BUN Testing, Vitamin D, Testosterone, ALT, Creatinine, Other Test Types) and Region - 2022 to 2032)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 自動視野分析器の世界市場2022～2032：製品種類別、エンドユーザー別、地域別
  • コンシューマーゲノミクスの世界市場2022～2032：用途別、地域別
  • 歯内治療用ファイルの世界市場2022～2032：種類別（手動、回転）、材料別（ステンレス、ニッケルチタン）、流通チャネル別（オフライン、オンライン）、エンドユーザー別（病院・OPD、歯科医院、その他）、地域別
  • 空圧止血帯の世界市場2022～2032：タ種類別、用途別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆